Clinical Considerations When Introducing Sodium-Glucose Co-Transporter 2 Inhibition in Patients With Heart Failure
Circulation Reports
doi 10.1253/circrep.cr-19-0080
Full Text
Open PDFAbstract
Available in full text
Date
January 10, 2020
Authors
Publisher
Japanese Circulation Society